By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Proteros Biostructures today said that it has entered into a drug discovery services agreement with the CHDI Foundation, a non-profit scientific organization focused on discovering and developing Huntington's disease therapies.

Under the alliance, Martinsried, Germany-based Proteros will provide structure-based drug discovery services to CHDI using its integrated discovery platform including proprietary X-ray crystallography tools.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.